Vertigo Clinical Trials

10 recruiting

Vertigo Trials at a Glance

15 actively recruiting trials for vertigo are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Islamabad, Moscow, and Kirov. Lead sponsors running vertigo studies include Foundation University Islamabad, Fondazione IRCCS Policlinico San Matteo di Pavia, and First Affiliated Hospital Xi'an Jiaotong University.

Browse vertigo trials by phase

Treatments under study

About Vertigo Clinical Trials

Looking for clinical trials for Vertigo? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vertigo trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vertigo clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Not Applicable

Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device

VertigoHearing LossFall Prevention+4 more
Stanford University350 enrolled1 locationNCT05365646
Recruiting

Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes

Meniere's DiseaseVertigoVestibular Migraine
IRCCS San Raffaele250 enrolled1 locationNCT07518069
Recruiting

Diagnostic Aid for Vertigo Patients

Vertigo
University Hospital, Strasbourg, France50 enrolled1 locationNCT07299487
Recruiting

Lost in the Labyrinth: Predicting Central Neurological Causes of Vertigo Dizziness and Unsteadiness in the Emergency Department. A Multicentre Cross-sectional Observational Study

DizzinessED With VertigoUnsteadiness
Fondazione IRCCS Policlinico San Matteo di Pavia825 enrolled1 locationNCT07287891
Recruiting
Not Applicable

Reducing Vertigo Associated With MRI Machines

VertigoDizziness
Johns Hopkins University100 enrolled1 locationNCT06062368
Recruiting
Phase 4

Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo

Autonomic DysfunctionVertigo
Valenta Pharm JSC160 enrolled4 locationsNCT06321341
Recruiting
Not Applicable

Effect of Wii Fit Training in Comparison to Vestibular Rehabilitation Training on Balance in Patients With Benign Paroxysmal Postional Vertigo

Benign Paroxysmal Positional VertigoVertigoBalance
Foundation University Islamabad38 enrolled1 locationNCT06738823
Recruiting
Phase 3

Comparison of Efficacy of Metoclopramide , Promethazine and Prochloroperazine in the Treatment of Vertigo.

Peripheral Vertigo
Oman Medical Speciality Board90 enrolled1 locationNCT05586763
Recruiting
Not Applicable

Personalized Treatment of Refractory BPPV

Benign Paroxysmal Positional VertigoPersonalized Medicine
Hospital Clinico Universitario de Santiago54 enrolled1 locationNCT06725966
Recruiting

Prevalence av BPPV Among Elderly in Primary Care

Benign Paroxysmal Positional Vertigo (BPPV)
Region Stockholm115 enrolled1 locationNCT06643702
Recruiting
Not Applicable

Effects of Epleys Maneuver Versus Semont-Plus Maneuver Combined with Brandt-Daroff Exercises on Dizziness and Quality of Life in Benign Paroxysmal Positional Vertigo

DizzinessBenign Paroxysmal Positional Vertigo (BPPV)
Foundation University Islamabad40 enrolled1 locationNCT06625281
Recruiting
Not Applicable

Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy

Benign Paroxysmal Positional VertigoMeniere DiseasePeripheral Vestibular Disorder+4 more
University of British Columbia50 enrolled1 locationNCT05424302
Recruiting

Cohort Study of Clinical and Neuroimaging Characteristics for BPPV Patients in China

BPPVVertigoVertigo, Peripheral
First Affiliated Hospital Xi'an Jiaotong University150 enrolled1 locationNCT06228196
Recruiting
Not Applicable

Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV

Benign Paroxysmal Positional Vertigo
Xi'an No.3 Hospital120 enrolled1 locationNCT06001047
Recruiting

The use of the Epley Omniax device in the treatment of Benign Paroxysmal Positional Vertigo (BPPV)

Benign Paroxysmal Positional Vertigo
Royal Victorian Eye and Ear Hospital100 enrolled1 locationACTRN12619001039178